These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25457058)

  • 41. Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries.
    Gasior P; Cheng Y; Xia J; Conditt GB; McGregor JC; Virmani R; Granada JF; Kaluza GL
    Cardiol J; 2020; 27(2):115-125. PubMed ID: 30155861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
    Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
    Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic analysis of a novel bioresorbable scaffold in porcine coronary artery model.
    Tenekecioglu E; Torii R; Bourantas CV; Cavalcante R; Sotomi Y; Zeng Y; Collet C; Crake T; Abizaid A; Onuma Y; Su S; Santoso T; Serruys PW
    Catheter Cardiovasc Interv; 2018 May; 91(6):1084-1091. PubMed ID: 28843033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-implantation shear stress assessment: an emerging tool for differentiation of bioresorbable scaffolds.
    Tenekecioglu E; Torii R; Katagiri Y; Chichareon P; Asano T; Miyazaki Y; Takahashi K; Modolo R; Al-Lamee R; Al-Lamee K; Colet C; Reiber JHC; Pekkan K; van Geuns R; Bourantas CV; Onuma Y; Serruys PW
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):409-418. PubMed ID: 30426299
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent Bioresorbable Vascular Scaffold by Optical Coherence Tomography Imaging at 5 Years.
    Moriyama N; Shishido K; Tobita K; Takada T; Ochiai T; Tsukuda S; Yamanaka F; Sugitatsu K; Mizuno S; Tanaka Y; Murakami M; Matsumi J; Takahashi S; Akasaka T; Saito S
    JACC Cardiovasc Interv; 2017 Jan; 10(2):e11-e13. PubMed ID: 28040440
    [No Abstract]   [Full Text] [Related]  

  • 47. Time does not heal all wounds: very late stent thrombosis eight years after implantation of a sirolimus-eluting stent due to positive remodelling, saccular evaginations and marked vascular inflammation.
    Orban M; Joner M; Riegger J; Steigerwald K; Tada T; Ibrahim T; Laugwitz KL; Byrne RA; Kastrati A; Massberg S
    EuroIntervention; 2013 Jul; 9(3):412-3. PubMed ID: 23034199
    [No Abstract]   [Full Text] [Related]  

  • 48. Longitudinal elongation, axial compression, and effects on strut geometry of bioresorbable vascular scaffolds: insights from 2- and 3-dimensional optical coherence tomography imaging.
    Ohno Y; Attizzani GF; Capodanno D; Tamburino CI; Longo G; Fujino Y; Capranzano P; Tamburino C
    JACC Cardiovasc Interv; 2015 Mar; 8(3):e35-e37. PubMed ID: 25703882
    [No Abstract]   [Full Text] [Related]  

  • 49. Early neoatherosclerosis after bioresorbable vascular scaffold implantation: insights from optical coherence tomography.
    Sato T; Richardt G; Abdel-Wahab M
    Coron Artery Dis; 2016 Nov; 27(7):616-7. PubMed ID: 27228185
    [No Abstract]   [Full Text] [Related]  

  • 50. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
    Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A
    Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5 Years of Serial Intravascular Imaging Outcomes of XINSORB Sirolimus-Eluting Bioresorbable Vascular Scaffold.
    Wu Y; Shen L; Yin J; Chen J; Ge L; Ge J
    JACC Cardiovasc Interv; 2019 Mar; 12(6):602-603. PubMed ID: 30660461
    [No Abstract]   [Full Text] [Related]  

  • 52. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
    Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
    JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug-eluting stents: will the transformation to bioabsorption make durable polymers obsolete?
    Waksman R
    Cardiovasc Revasc Med; 2013; 14(2):69-70. PubMed ID: 23497773
    [No Abstract]   [Full Text] [Related]  

  • 54. Optical Coherence Tomography Findings in Patients With Recanalized Coronary Thrombi Treated With Bioresorbable Vascular Scaffolds.
    Cuesta J; García-Guimaraes M; Bastante T; Rivero F; Alvarado T; Alfonso F
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28698292
    [No Abstract]   [Full Text] [Related]  

  • 55. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 56. Embolization of Fractured Bioresorbable Scaffold Struts: Insights From 2- and 3-Dimensional Optical Coherence Tomography.
    Capranzano P; Francaviglia B; Capodanno D; Di Salvo ME; Tamburino CI; Santagati FM; Tamburino C
    JACC Cardiovasc Interv; 2016 Feb; 9(4):e37-e38. PubMed ID: 26777323
    [No Abstract]   [Full Text] [Related]  

  • 57. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.
    Meredith IT; Verheye S; Weissman NJ; Barragan P; Scott D; Valdés Chávarri M; West NE; Kelbæk H; Whitbourn R; Walters DL; Kubica J; Thuesen L; Masotti M; Banning A; Sjögren I; Stables RH; Allocco DJ; Dawkins KD
    EuroIntervention; 2013 Jul; 9(3):308-15. PubMed ID: 23872647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
    Azzalini L; Al-Hawwas M; L'Allier PL
    EuroIntervention; 2015 May; 11(1):e1-2. PubMed ID: 25982486
    [No Abstract]   [Full Text] [Related]  

  • 60. Flare spots in intravascular optical coherence tomography images of bioabsorbable stents.
    Elahi S; Milner TE; Rapoza RJ; Dijkstra J; Feldman MD
    JACC Cardiovasc Imaging; 2014 Nov; 7(11):1174-5. PubMed ID: 25459600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.